Intrinsiqs

Is Organogenesis Holdings Inc. overvalued?

Organogenesis Holdings Inc. (ORGO) looks overvalued — trading about 40% above its fair value.

Overvalued
Current price $1.38 Fair value $0.82
Price
$1.38
Fair value
$0.82
Current P/E
46.0
Normal P/E
27.5
Market cap
$177.6M
Dividend yield
0.0%
Return on equity
-24.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ORGO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated